Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Therapeutic Advances in Medical Oncology|July 29, 2025
Role of immune checkpoint inhibitor combinations in resectable and unresectable, embolization-eligible hepatocellular carcinomaBrandon M Meyers, Howard J Lim, Mayur Brahmania, et al.
Canadian Journal of Gastroenterology & Hepatology|December 10, 2020
Efficacy and Prognostic Factors for Y-90 Radioembolization (Y-90) in Metastatic Neuroendocrine Tumors with Liver MetastasesErica S Tsang, Jonathan M Loree, Janine M Davies, et al.
NPJ Precision Oncology|October 25, 2022
A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in CanadaDean A Regier, Samantha Pollard, Melanie McPhail, et al.
Brain Imaging and Behavior|October 23, 2015
Altered neural activation during prepotent response inhibition in breast cancer survivors treated with chemotherapy: an fMRI studyJulia W Y Kam, Lara A Boyd, Chun L Hsu, et al.
The Oncologist|March 13, 2020
Medical Oncologists' Perspectives on How the Results of the IDEA Collaboration Impact the Adjuvant Treatment of Stage III Colon CancerIrene S Yu, Allan A L Pereira, Michael Lee, et al.
American Journal of Clinical Oncology|December 1, 2018
Outcomes and Characteristics of Patients Receiving Second-line Therapy for Advanced Pancreatic CancerErica S Tsang, Hui-Li Wong, Ying Wang, et al.
Lancet Regional Health. Americas|November 28, 2024
Real-world cost-effectiveness of multi-gene panel sequencing to inform therapeutic decisions for advanced non-small cell lung cancer: a population-based studyEmanuel Krebs, Deirdre Weymann, Cheryl Ho, et al.
Genes, Chromosomes & Cancer|September 20, 2024
Diagnostic and Therapeutic Implications of a FUS::TFCP2 Fusion and ALK Activation in a Metastatic RhabdomyosarcomaVeronika Csizmok, Cameron J Grisdale, Laura M Williamson, et al.
Clinical Colorectal Cancer|January 1, 2022
Impact of Tumor Location on Patient Outcomes in Small Bowel CancersIrene S Yu, Zamzam Al-Hashami, Parv Chapani, et al.
BMC Cancer|February 25, 2010
Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survivalDavid F Schaeffer, Daniel R Owen, Howard J Lim, et al.
Pageof 8